(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-1.16%) $1.619
(0.30%) $2 349.60
(-0.47%) $27.23
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
@ $1.237
Issued: 14 Feb 2024 @ 09:30
Return: -36.44%
Previous signal: Feb 13 - 09:30
Previous signal:
Return: -0.24 %
Live Chart Being Loaded With Signals
Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight...
Stats | |
---|---|
Today's Volume | 549 302 |
Average Volume | 1.53M |
Market Cap | 48.13M |
EPS | $0 ( 2024-03-05 ) |
Next earnings date | ( $-0.870 ) 2024-05-14 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.120 |
ATR14 | $0.00400 (0.51%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-02-15 | Chaubey Alka | Sell | 1 081 | Common Stock |
2024-02-15 | Oldakowski Mark | Sell | 1 229 | Common Stock |
2024-02-15 | Holmlin R. Erik | Sell | 3 073 | Common Stock |
2024-02-15 | Dixon Jonathan V. | Sell | 402 | Common Stock |
2023-09-18 | Oldakowski Mark | Buy | 20 000 | Common Stock |
INSIDER POWER |
---|
83.54 |
Last 99 transactions |
Buy: 20 105 134 | Sell: 833 309 |
Volume Correlation
Bionano Genomics Inc Correlation
10 Most Positive Correlations | |
---|---|
MMAT | 0.97 |
AUDC | 0.965 |
OPINL | 0.964 |
ARVL | 0.962 |
ATNF | 0.959 |
HFWA | 0.954 |
OPI | 0.952 |
WATT | 0.952 |
VIEW | 0.951 |
ADN | 0.95 |
10 Most Negative Correlations | |
---|---|
BRIVU | -0.974 |
TIOA | -0.96 |
VLAT | -0.957 |
BRIV | -0.956 |
MSDA | -0.953 |
MSDAU | -0.953 |
TIOAU | -0.952 |
LDHA | -0.947 |
HEWG | -0.945 |
OMAB | -0.945 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Bionano Genomics Inc Correlation - Currency/Commodity
Bionano Genomics Inc Financials
Annual | 2023 |
Revenue: | $36.12M |
Gross Profit: | $9.57M (26.49 %) |
EPS: | $-6.81 |
FY | 2023 |
Revenue: | $36.12M |
Gross Profit: | $9.57M (26.49 %) |
EPS: | $-6.81 |
FY | 2022 |
Revenue: | $27.80M |
Gross Profit: | $5.95M (21.38 %) |
EPS: | $-4.58 |
FY | 2021 |
Revenue: | $17.98M |
Gross Profit: | $3.87M (21.54 %) |
EPS: | $-0.260 |
Financial Reports:
No articles found.
Bionano Genomics Inc
Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight. The company also provides Saphyr and Bionano compute servers; and NxClinical which offers one system for analysis and interpretation of genomic variants from microarray and next-generation sequencing data for cytogenetics and molecular genetics. In addition, it offers testing and laboratory services comprising FirstStepDx PLUS, a chromosomal microarray for identifying an underlying genetic cause in individuals with autism spectrum disorder, developmental delay, and intellectual disability; Fragile X syndrome (FXS) testing services; NextStepDx PLUS, a exome sequencing test to identify genetic variants that are associated with disorders of childhood development; EpiPanelDx PLUS, a genetic testing panel for patients who have experienced seizures, infantile spasms, encephalopathy, or febrile seizures; PGx test, which identifies over 60 alleles in 11 genes. The company was founded in 2003 and is headquartered in San Diego, California.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators